| Name | Title | Contact Details |
|---|
Jemar Co is a Valdosta, GA-based company in the Software and Internet sector.
Information is power - if you have the right tools. Alexa`s suite of intuitive analytics products transforms data into meaningful insights that lead to competitive advantage for your company. At Alexa, we focus exclusively on delivering the richest and most meaningful analytics tools for our customers. Our obsession is to empower customers through compelling and actionable insights that drive measurable results for their business. At Alexa, we believe strongly in substance over style, which means you can count on getting the exact insights you need without having to navigate through extraneous content to get the information you need right now. Founded in 1996, Alexa is a global pioneer in the world of analytical insight. Our vast experience means we`ve dealt with all of the pitfalls and tripped over all of the landmines, and over time, developed the most robust and accurate web analytics service of any provider. As a wholly-owned subsidiary of Amazon.com, a career at Alexa provides an extraordinary opportunity to work in a fun and challenging environment while enjoying the stability and rewards of working for an established corporation.
Lucidum is the asset discovery company that eliminates blind spots across cloud, security and IT operations. Fortune 500 companies rely on the Lucidum platform and its patent-pending machine learning to discover, triangulate and identify all assets – even previously unknown unknowns – delivering visibility essential to truly secure, manage, and transform your enterprise. Backed by GGV Capital and Silicon Valley CISO Investors (SVCI), Lucidum is based in San Jose, California.
Cyber Security Works is a leading cybersecurity services company that provides risk-based vulnerability management and penetration services. From infrastructure to code, we test your vulnerabilities and help you remediate them in priority.
Perthera, Inc. is a service company that helps guide patients and their physicians to the best cancer treatment options available by bridging the gap between molecular testing and patient therapy. We provide a more complete view of the molecular pathways driving advanced stage cancer than any other company. By combining genomics, proteomics and clinical history, Perthera delivers a comprehensive molecular analysis of a patient`s tumor and identifies the best available FDA approved therapies and clinical trials for each individual patient.